Discontinued — last reported Q4 '19

Other

2029

Abbott 2029 increased by 11.5% to $650.00M in Q4 2025 compared to the prior quarter. Over 3 years (FY 2022 to FY 2025), 2029 shows relatively stable performance with a 2.7% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementBalance Sheet Statement
SectionOther
CategoryLiquidity
SignalLower is better
VolatilityStable
First reportedQ4 2018
Last reportedQ4 2019

How to read this metric

A well-distributed maturity schedule reduces the risk of liquidity crises during economic downturns.

Detailed definition

This represents the specific portion of long-term debt principal scheduled for repayment during the 2029 fiscal year, re...

Peer comparison

Similar to other large-cap peers, the company manages its debt maturity to align with long-term contract cash flows.

Metric ID: other_long_term_debt_maturities_repayments_of_principal__8a0a63

Historical Data

4 periods
 Q4 '22Q4 '23Q4 '24Q4 '25
Value$600.00M$651.00M$583.00M$650.00M
QoQ Change+8.5%-10.4%+11.5%
YoY Change+8.5%-10.4%+11.5%
Range$583.00M$651.00M
Avg YoY Growth+3.2%
Median YoY Growth+8.5%

2029 at Other Companies

Frequently Asked Questions

What is Abbott's 2029?
Abbott (ABT) reported 2029 of $650.00M in Q4 2025.
What is the long-term trend for Abbott's 2029?
Over 3 years (2022 to 2025), Abbott's 2029 has grown at a 2.7% compound annual growth rate (CAGR), from $600.00M to $650.00M.
What does 2029 mean?
The amount of long-term debt principal that must be repaid in 2029.